Osteoarthritis (OA) is a highly prevalent whole-joint disease that causes disability and pain
and affects a patient's quality of life. However, currently, there is a lack of effective early …

Extracellular vesicles (EVs) present a great potential for the development of new treatments
in the biomedical field. To be used as therapeutics, many different sources have been used …

Osteoarthritis (OA) is the leading cause of disability worldwide. Considerable progress has
been made using stem-cell-derived therapy. Increasing evidence has demonstrated that the …

The use of platelet-rich plasma (PRP) has gained increasing interest in recent decades. The
platelet secretome contains a multitude of growth factors, cytokines, chemokines, and other …

Autologous blood products, such as platelet-rich plasma (PRP), are gaining increasing
interest in different fields of regenerative medicine. Although growth factors, the main …

Osteoarthritis (OA) is a prevalent and debilitating age-related joint disease characterized by
articular cartilage degeneration, synovial membrane inflammation, osteophyte formation, as …

Osteoarthritis (OA) is a chronic joint disease characterized by inflammation, gradual
destruction of articular cartilage, joint pain, and functional limitations that eventually lead to …

Purpose To determine the efficacy of autologous platelet-and extracellular vesicle-rich
plasma (PVRP) to treat chronic postoperative temporal bone cavity inflammation (CPTBCI) …

Cartilage breakdown, inflammation and pain are hallmark symptoms of osteoarthritis, and
autologous blood products such as citrate-anticoagulated platelet-rich plasma (CPRP) or …

Osteoarthritis (OA) is a kind of degenerative disease, which is caused by many factors such
as aging, obesity, strain, trauma, congenital joint abnormalities, joint deformities. Exosomes …